Switzerland and US sign drug inspection agreement
European Pharmaceutical Review
JANUARY 16, 2023
Under the agreement with the Swiss Confederation (Switzerland), the Swiss Agency for Therapeutic Products (Swissmedic) and the US Food and Drug Administration (FDA) will be able to utilise each other’s GMP inspections of pharmaceutical manufacturing facilities, avoiding the need for duplicate inspections.
Let's personalize your content